Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > OMGA Omega Therapeutics > Detailed Quotes

OMGA Omega Therapeutics

Watchlist
6.300
-0.400-5.97%
Close  12/07 16:00 ET
6.3000.0000.00%
Post Mkt Price 12/07 16:01 ET
High
6.905
Open
6.800
Turnover
251.28K
Low
6.190
Pre Close
6.700
Volume
38.36K
Market Cap
302.71M
P/E(TTM)
Loss
52wk High
15.790
Shares
48.05M
P/E(Static)
Loss
52wk Low
1.975
Float Cap
110.44M
Bid/Ask %
0.00%
Historical High
31.410
Shs Float
17.53M
Volume Ratio
0.93
Historical Low
1.975
Dividend TTM
--
Div Yield TTM
--
P/B
2.26
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.22%
Amplitude
10.67%
Avg Price
6.550
Lot Size
1
Float Cap
110.44M
Bid/Ask %
0.00%
Historical High
31.410
Shs Float
17.53M
Volume Ratio
0.93
Historical Low
1.975
Dividend TTM
--
P/B
2.26
Dividend LFY
--
Turnover Ratio
0.22%
Amplitude
10.67%
Avg Price
6.550
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
CEO: Mr. Mahesh Karande
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist